| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 35 |
| 1 | ACETAMINOPHEN | 23 |
| 2 | PANTOPRAZOLE | 17 |
| 3 | ALEMTUZUMAB | 16 |
| 4 | DIMENHYDRINATE | 16 |
| 5 | GABAPENTIN | 16 |
| 6 | METHYLPREDNISOLONE | 16 |
| 7 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 15 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 15 |
| 9 | AMLODIPINE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLUNISAL | 4 | 0.0049 |
| 1 | DIMENHYDRINATE | 16 | 0.0015 |
| 2 | CIMETIDINE | 10 | 0.0010 |
| 3 | OMEGA-3-ACID ETHYL ESTERS | 2 | 0.0010 |
| 4 | AMLODIPINE AND ATORVASTATIN | 4 | 0.0010 |
| 5 | ALEMTUZUMAB | 16 | 0.0008 |
| 6 | ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE | 1 | 0.0007 |
| 7 | SPARSENTAN | 5 | 0.0007 |
| 8 | METHYLPREDNISOLONE ACETATE | 5 | 0.0006 |
| 9 | ASFOTASE ALFA | 5 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 36 |
| 1 | Corticosteroid [EPC] | 27 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 16 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 16 |
| 5 | Proton Pump Inhibitor [EPC] | 16 |
| 6 | Expectorant [EPC] | 15 |
| 7 | Factor Xa Inhibitor [EPC] | 15 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 15 |
| 9 | Calcium Channel Blocker [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 16 | 0.0008 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 5 | 0.0005 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 5 | 0.0003 |
| 3 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 5 | Nitrofuran Antibacterial [EPC] | 4 | 0.0002 |
| 6 | Antisense Oligonucleotide [EPC] | 2 | 0.0002 |
| 7 | Thiazide-like Diuretic [EPC] | 6 | 0.0001 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 15 | 0.0001 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |